Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $168.46 USD
Change Today +2.49 / 1.50%
Volume 3.8M
As of 5:20 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul J. Reider Ph.D.

Former Vice President of Chemical Research, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. Paul J. Reider, Ph.D. is an Advisor at Tetraphase Pharmaceuticals, Inc. He also serves as Senior Editor of Current Opinion in Drug Discovery and Development and Science of Synthesis. Dr. Reider is Professor in Department of Chemistry at Princeton University. Dr. Reider joined the faculty of Princeton University in 2008 where his research is focused on new drugs for Malaria, TB and other neglected diseases. He was an Advisor at PureTech Ventures. He served as Vice ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Princeton University
BA
New York University
PhD
The University of Vermont

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $168.46 USD +2.49

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.